October 2020 PMID 31190484

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis.

Jae Heon Kim, Sung Ryul Shim, Yash Khandwala, Francesco Del Giudice, Simon Sorensen, Benjamin I Chung

Full text PDF Download social card

Mentions

Peak: 4 in Dec 2024

across 2 sources since Sep 2020

Extended reach

78,945

potential audience

Total likes

1,626

Video views

76,662

Mentions per month

Sep 2020 – Dec 2024

Where it's discussed

X / Twitter5 posts
YouTube2 videos

AI synopsis

What people are saying

Discussions reflect a cautious tone, with some posts highlighting the importance of the study for patient safety, like mentions of 'further research needed,' while others downplay its significance. The tone ranges from analytical to dismissive, indicating mixed engagement and perceived impact.

AgreementNeither agree nor disagree

The discussions show mixed opinions, with some posts acknowledging the study's findings while others express skepticism or indifference.

InterestModerate interest

There is moderate curiosity, especially regarding the potential link between medication and depression, but some posts dismiss the topic as less relevant.

EngagementModerate engagement

Posts engage by mentioning the methodology and implications, but mostly in a superficial manner without deep analysis.

ImpactNeutral impact

The overall perceived impact appears limited, as users either question the significance or show mild concern, rather than advocating for immediate change.

Abstract in brief

This meta-analysis investigated whether taking 5-alpha reductase inhibitors (5ARIs), drugs commonly used for benign prostatic hyperplasia (BPH) and hair loss, increases the risk of depression, analyzing data from over 200,000 patients.
The study found that overall, the risk of depression with 5ARI treatment is not significantly high, but in certain subgroups or based on age, the risk might be slightly increased, indicating the need for further research.
The results provide useful information for doctors and patients, but more studies are needed to confirm whether 5ARI medications have a true impact on the risk of depression.]

Read the full abstract

All mentions

Finasteride's Role in Reducing Dyskinesia in Parkinson's Disease

This study investigates finasteride, a 5alpha reductase inhibitor, and its potential to decrease levodopa-induced dyskinesia in rat models of Parkinson's disease by blocking neurosteroid synthesis that affects dopamine…

Haircafe · Jul 17, 2022 47,238 views

Understanding 5AR Isoenzymes and Their Role in Hormone Regulation

This video explains 5AR isoenzymes, including the often-misunderstood Type 3, and discusses their impact on hormone regulation and neurosteroid production.

Haircafe · Jan 29, 2023 29,424 views

ねこ先生@AGA治療エビデンス解説

@doctor_neco · X

Dec 14, 2024 · 3 shares · 131 followers View post →

bull吉社長@筋トレ大好き

@bullkichi_water · X

Dec 1, 2024 · 3 shares · 343 followers View post →

ゆとり｜AGAケアと睡眠でカッコいい大人になろう

@kae_extort · X

Dec 1, 2024 · 3 shares · 1,408 followers View post →

ねこ先生@AGA治療エビデンス解説

@doctor_neco · X

Dec 1, 2024 · 3 likes · 3 shares · 131 followers View post →

World J Mens Health

@WJMensHealth · X

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis https://t.co/qF9yYEGevZ

Sep 17, 2020 · 246 followers View post →